
The treatment cannot be granted full approval due to ongoing litigation.
Kenny Walter is an editor with HCPLive. Prior to joining MJH Life Sciences in 2019, he worked as a digital reporter covering nanotechnology, life sciences, material science and more with R&D Magazine. He graduated with a degree in journalism from Temple University in 2008 and began his career as a local reporter for a chain of weekly newspapers based on the Jersey shore. When not working, he enjoys going to the beach and enjoying the shore in the summer and watching North Carolina Tar Heel basketball in the winter.

The treatment cannot be granted full approval due to ongoing litigation.

Few studies have focused on the psychosocial adjustments of siblings of children with ADHD.

In recent years there has been an expansion of trials in different methods of treatment settings, providers, countries, and delivery methods.

Investigators found 11.9% of patients with IBD in a survey were considered vaccine hesitant.

An estimated 23% of healthcare personnel contract influenza annually.

There currently is not an approved treatment for EoE by the US Food and Drug Administration.

There was a significant risk-adjusted trend toward decreasing inpatient mortality from 8.7% in 2010 to 7.4% in 2018 for readmissions within 30 days.

Between 2011-2018, hospital admissions for CDI has decreased dramatically.

A combination of poor performance and methodological limitations were found for the machine learning models.

Patients with the absence of urgency had significantly greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.

ACG represents the first major in-person conference since the COVID-19 pandemic.

Dr. Feuerstadt presented data about RBX2660 during the recent ACG 2021 meeting.

An absence of urgency was associated with greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.

Approximately 88% of patients treated with SER-109 achieved a sustained clinical response at 8 weeks.

Patients in the open-label extension of the OASIS study saw increases in Inflammatory Bowel Disease Questionnaire (IBDQ) scores.

PROSE allows patients to report their symptoms of dysphagia in real-time.

Investigators found fistulizing Crohn’s disease increases the healthcare burden and lengthens the duration of hospital stays in patients with acute kidney injuries.

It can be challenging to find a suitable donor for fecal microbiota transplantation.

RBX2660 is a a standardized, stabilized, investigational microbiota-based live therapeutic being studied for the treatment of C difficile infections.

Patients with Crohn's disease often also suffer from kidney dysfunction.

This patient group had higher odds of death and longer lengths of hospital stays.

Patients in both the ADVANCE and MOTIVATE studies achieved enhanced clinical response and endoscopic response.

Hypertension rates were low in both ulcerative colitis and multiple sclerosis patients treated with ozanimod, regardless of concurrent SNRI/SSRI use.

Lactate dehydrogenase levels were significantly higher in patients with Influenza A.

Dr. Glanzman presented during AAP 2021 about executive function impairments in patients with ADHD.

Many of the measures put in place because of COVID-19 have also helped to reduce the rates of C difficile infections.

There was a higher risk of type 2 diabetes in patients with fibrosis stage F4 compared to patients with stage F0 or F2.

Students with ADHD have struggled with virtual schooling during the COVID-19 pandemic.

Recent studies have shown the majority of potential FMT donors are ultimately rejected.

There was a correlation between anxiety scores and COVID-19 cases.